Concepedia

Cold agglutinin disease following SARS‐CoV‐2 and <i>Mycoplasma pneumoniae</i> co‐infections

Chatphatai Moonla, Phandee Watanaboonyongcharoen, Gompol Suwanpimolkul, Leilani Paitoonpong, Watsamon Jantarabenjakul, Chantiya Chanswangphuwana, Chantana Polprasert, Ponlapat Rojnuckarin, Opass Putcharoen

Clinical Case Reports · 2020 · 11 citations · 13 references

DOIFull text

Open access

Concepts

Abstract

Abstract SARS‐CoV‐2 and other respiratory co‐infections may occur. As Mycoplasma pneumoniae and various viruses can cause cold agglutinin disease (CAD), the presence of CAD in COVID‐19 patients should indicate the need of investigations for those pathogens.

References

13

Clinical Characteristics of Coronavirus Disease 2019 in China

Wei‐jie Guan, Zhengyi Ni, Yu Hu et al. · New England Journal of Medicine · 2020 · 31.2K citations · Full text

, , +10

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Nanshan Chen, Min Zhou, Xuan Dong et al. · The Lancet · 2020 · 22.7K citations · Full text

, , +13

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · International Journal of Antimicrobial Agents · 2020 · 5K citations · Full text

, , +10

Prognosis and Outcomes of Patients With Community-Acquired Pneumonia

Michael J. Fine · JAMA · 1996 · 1.3K citations

, , +10

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

Eli S. Rosenberg, Elizabeth Dufort, Tomoko Udo et al. · JAMA · 2020 · 1.2K citations · Full text

, , +13